問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCT-L05-301
Completed

2022-06-01 - 2024-12-31

Phase III

Terminated11

  • Sponsor

  • Trial scale

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Tzung-Dau Wang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator I-Chang Hsieh

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳清埤

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tsung-Hsien Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chern-En Chiang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 張正坤

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 謝慕揚

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳冠群

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 鄭正一

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Chun-Yao Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    67 participants

  • Global

    804 participants